Product Description: Bavdegalutamide (ARV-110) is an orally active, specific androgen receptor (AR) PROTAC degrader. Bavdegalutamide promotes ubiquitination and degradation of AR. Bavdegalutamide can be used for the research of prostate cancer (Pink: AR ligand (HY-168299); Blue: E3 ligase ligand (HY-W093272); Black: linker (HY-W091986))[1].
Applications: Cancer-programmed cell death
Formula: C41H43ClFN9O6
References: [1]Taavi Neklesa, et al. ARV-110: An androgen receptor PROTAC degrader for prostate cancer. American Association for Cancer Research. 2018. 78 (13): pp. 5236./[2]Taavi K Neklesa,et al. ARV-110: an oral androgen receptor PROTAC degrader for prostate cancer. GU ASCO 2019
CAS Number: 2222112-77-6
Molecular Weight: 812.29
Compound Purity: 99.64
Research Area: Cancer
Solubility: DMSO : 26.67 mg/mL (ultrasonic;warming;adjust pH to 3 with HCl;heat to 80°C)